Genome Compiler closed a Seed round (amount undisclosed) in Oct 2013. The company is based in Tel Aviv-Yafo, Israel. Investors in the round: Techammer. Data as of 7 Aug 2026.
Amount undisclosed or unconverted.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
